MENU
VSTM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Verastem (VSTM) Ownership - Who owns Verastem?
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
117 Kendrick Street
Phone
+1 781 292-4200
Employees
73
Web
https://www.verastem.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
386.17M
P/E Ratio
N/A
Total Cash
113.18M
Projected Growth
N/A
Total Debt
41.43M
Revenue
10M
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
2.20
Total Debt/Equity
N/A
Revenue/Share
0.28 USD as % of share price
Fundamentals
VSTM
Capitalization
386M
P/E Ratio
N/A
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
2.20
Total Debt
41.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.28%
Revenue
10M
ROE
N/A
Book Value
11.1M
P/B Ratio
27.47
Cash Flow
N/A
Earnings
-3.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
3.23
Current Revenue Per Employee
136986.30
Dividends Per Share - Security
N/A
EBITDA
-88.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-61.78
Shares Held By Institutions
602M
Shares Outstanding - Current
51.5M
Total Liabilities
94.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
45.068
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company that discovers and develops drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
117 Kendrick Street
Phone
+1 781 292-4200
Employees
73
Web
https://www.verastem.com